Droxicainide

This classification denotes an antiarrhythmic agent with the molecular formula C16H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) J6W196LMV3, chemically known as 2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-n-(2-hydroxyethyl)-, monohydrochloride, (+-)- but more generally known as droxicainide, which bears US NIH Compound Identifier 135791. European Medicines Agency schedules Droxicainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06418MIG. The term DROXICAINIDE is an International Non-Proprietary Name. DROXICAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule droxicainide under HS 29333999 and SITC 51574. As of Q4 2014, DROXICAINIDE remains US FDA's Preferred Term for this commodity. Droxicainide bears US NLM identifiers UMLS ID C0058764 and NCI Concept Code C72579. SMILES: CL.O=C(N(C1C(CCCC1C)C)CCO)C1NCCCC1.